false12-312022Q20001839550P10DP3DP10D0.250.250.25P10Y00018395502022-01-012022-06-300001839550faca:RedeemableWarrantsMember2022-01-012022-06-300001839550faca:PublicSharesMember2022-01-012022-06-300001839550us-gaap:CommonClassAMember2022-01-012022-06-300001839550us-gaap:CommonClassBMember2022-08-150001839550us-gaap:CommonClassAMember2022-08-150001839550faca:CommonClassLMember2022-08-1500018395502021-12-3100018395502022-06-300001839550us-gaap:CommonClassAMember2022-06-300001839550us-gaap:CommonClassAMember2021-12-310001839550us-gaap:CommonClassBMember2021-12-310001839550faca:CommonClassLMember2022-06-300001839550us-gaap:CommonClassBMember2022-06-300001839550faca:CommonClassLMember2021-12-3100018395502021-01-012021-06-3000018395502021-04-012021-06-3000018395502022-04-012022-06-300001839550us-gaap:CommonClassAMember2021-04-012021-06-300001839550us-gaap:CommonClassAMember2022-04-012022-06-300001839550us-gaap:CommonClassBMember2021-04-012021-06-300001839550us-gaap:CommonClassBMember2022-04-012022-06-300001839550faca:CommonClassLMember2021-04-012021-06-300001839550faca:CommonClassLMember2022-04-012022-06-300001839550faca:CommonClassLMember2022-01-012022-06-300001839550us-gaap:CommonClassBMember2022-01-012022-06-300001839550faca:CommonClassLMember2021-01-012021-06-300001839550us-gaap:CommonClassAMember2021-01-012021-06-300001839550us-gaap:CommonClassBMember2021-01-012021-06-300001839550faca:CommonClassLMemberus-gaap:CommonStockMember2020-12-310001839550us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-12-310001839550us-gaap:RetainedEarningsMember2021-12-3100018395502020-12-310001839550us-gaap:CommonClassAMemberus-gaap:CommonStockMember2020-12-310001839550us-gaap:CommonClassBMemberus-gaap:CommonStockMember2020-12-310001839550us-gaap:AdditionalPaidInCapitalMember2020-12-310001839550us-gaap:RetainedEarningsMember2020-12-310001839550faca:CommonClassLMemberus-gaap:CommonStockMember2021-12-310001839550us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-12-310001839550us-gaap:AdditionalPaidInCapitalMember2021-12-310001839550us-gaap:AdditionalPaidInCapitalMember2021-04-012021-06-300001839550us-gaap:RetainedEarningsMember2021-04-012021-06-300001839550us-gaap:CommonStockMemberus-gaap:CommonClassBMember2021-04-012021-06-300001839550us-gaap:CommonStockMemberus-gaap:CommonClassAMember2021-04-012021-06-300001839550us-gaap:CommonStockMemberfaca:CommonClassLMember2021-04-012021-06-300001839550us-gaap:RetainedEarningsMember2022-04-012022-06-300001839550us-gaap:CommonStockMemberus-gaap:CommonClassAMember2022-04-012022-06-300001839550us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-3100018395502021-01-012021-03-310001839550faca:CommonClassLMemberus-gaap:CommonStockMember2021-01-012021-03-310001839550us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-01-012021-03-310001839550us-gaap:CommonStockMemberus-gaap:CommonClassBMember2021-01-012021-03-310001839550us-gaap:RetainedEarningsMember2021-01-012021-03-3100018395502022-01-012022-03-310001839550us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310001839550faca:CommonClassLMemberus-gaap:CommonStockMember2022-01-012022-03-310001839550us-gaap:CommonStockMemberus-gaap:CommonClassAMember2022-01-012022-03-310001839550us-gaap:CommonClassBMemberus-gaap:CommonStockMember2022-01-012022-03-310001839550us-gaap:RetainedEarningsMember2022-01-012022-03-310001839550us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-300001839550us-gaap:CommonStockMemberus-gaap:CommonClassBMember2022-04-012022-06-300001839550faca:CommonClassLMemberus-gaap:CommonStockMember2022-04-012022-06-300001839550us-gaap:AdditionalPaidInCapitalMember2021-03-310001839550us-gaap:RetainedEarningsMember2021-03-310001839550us-gaap:CommonStockMemberus-gaap:CommonClassAMember2022-03-310001839550us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-03-310001839550faca:CommonClassLMemberus-gaap:CommonStockMember2021-03-310001839550us-gaap:RetainedEarningsMember2022-03-310001839550us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-03-3100018395502021-03-3100018395502022-03-310001839550us-gaap:AdditionalPaidInCapitalMember2022-03-310001839550us-gaap:AdditionalPaidInCapitalMember2022-06-300001839550us-gaap:CommonStockMemberus-gaap:CommonClassBMember2022-03-310001839550us-gaap:CommonClassBMemberus-gaap:CommonStockMember2022-06-300001839550us-gaap:CommonStockMemberfaca:CommonClassLMember2022-06-300001839550us-gaap:CommonClassAMemberus-gaap:CommonStockMember2022-06-300001839550faca:CommonClassLMemberus-gaap:CommonStockMember2022-03-310001839550us-gaap:RetainedEarningsMember2022-06-300001839550us-gaap:RetainedEarningsMember2021-06-3000018395502021-06-300001839550us-gaap:CommonStockMemberus-gaap:CommonClassBMember2021-06-300001839550us-gaap:CommonStockMemberfaca:CommonClassLMember2021-06-300001839550us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-06-300001839550us-gaap:AdditionalPaidInCapitalMember2021-06-300001839550us-gaap:IPOMemberfaca:PublicSharesMember2021-02-232021-02-230001839550faca:PublicSharesMemberus-gaap:OverAllotmentOptionMember2021-02-232021-02-230001839550us-gaap:PrivatePlacementMemberfaca:PrivatePlacementWarrantsMember2021-02-230001839550us-gaap:OverAllotmentOptionMemberfaca:PublicSharesMember2021-02-230001839550us-gaap:IPOMemberfaca:PublicSharesMember2021-02-230001839550faca:PrivatePlacementWarrantsMemberus-gaap:PrivatePlacementMember2021-02-232021-02-230001839550us-gaap:IPOMemberus-gaap:CommonClassAMember2021-02-230001839550us-gaap:IPOMemberfaca:RedeemableWarrantsMember2021-02-2300018395502021-02-2300018395502021-02-232021-02-230001839550srt:MaximumMember2022-01-012022-06-300001839550srt:MaximumMember2021-02-230001839550us-gaap:InvestorMember2021-02-232021-02-230001839550faca:PromissoryNoteMembersrt:MaximumMemberus-gaap:InvestorMember2021-02-230001839550faca:WorkingCapitalLoansMember2022-06-300001839550faca:WorkingCapitalLoansMember2021-12-310001839550us-gaap:InvestorMember2022-01-012022-06-300001839550srt:RestatementAdjustmentMember2022-04-012022-06-300001839550srt:RestatementAdjustmentMember2022-01-012022-06-300001839550us-gaap:IPOMember2021-02-230001839550us-gaap:IPOMember2021-02-232021-02-230001839550us-gaap:IPOMember2021-01-012021-12-310001839550faca:RedeemableWarrantsMemberus-gaap:IPOMember2021-01-012021-12-310001839550us-gaap:IPOMemberus-gaap:CommonClassAMember2021-01-012021-12-3100018395502021-01-012021-12-310001839550us-gaap:IPOMember2022-01-012022-06-300001839550us-gaap:CommonClassAMemberus-gaap:IPOMember2021-12-310001839550us-gaap:IPOMemberus-gaap:CommonClassAMember2022-06-300001839550faca:InitialPublicOfferingAndPrivatePlacementMember2022-01-012022-06-300001839550srt:MinimumMemberfaca:RedeemableWarrantsMemberus-gaap:CommonClassAMemberfaca:WarrantsAndRightsSubjectToMandatoryRedemptionOneMember2022-06-300001839550faca:RedeemableWarrantsMemberfaca:AdditionalOfferingMembersrt:MaximumMember2022-06-300001839550faca:WarrantsAndRightsSubjectToMandatoryRedemptionTwoMemberfaca:RedeemableWarrantsMemberus-gaap:CommonClassAMember2022-06-300001839550faca:RedeemableWarrantsMemberus-gaap:CommonClassAMember2022-06-300001839550faca:RedeemableWarrantsMemberus-gaap:CommonClassAMember2022-01-012022-06-300001839550faca:RedeemableWarrantsMembersrt:MinimumMemberfaca:AdditionalOfferingMember2022-01-012022-06-300001839550faca:RedeemableWarrantsMemberfaca:AdditionalOfferingMember2022-01-012022-06-300001839550faca:AdditionalOfferingMemberfaca:WarrantsAndRightsSubjectToMandatoryRedemptionOneMemberfaca:RedeemableWarrantsMember2022-01-012022-06-300001839550faca:RedeemableWarrantsMemberfaca:AdditionalOfferingMember2022-06-300001839550us-gaap:CommonClassAMemberfaca:RedeemableWarrantsMemberfaca:WarrantsAndRightsSubjectToMandatoryRedemptionOneMember2022-06-300001839550us-gaap:CommonClassAMemberfaca:WarrantsAndRightsSubjectToMandatoryRedemptionTwoMemberfaca:RedeemableWarrantsMember2022-01-012022-06-300001839550faca:RedeemableWarrantsMemberus-gaap:CommonClassAMemberfaca:WarrantsAndRightsSubjectToMandatoryRedemptionOneMember2022-01-012022-06-300001839550faca:PrivatePlacementWarrantMemberus-gaap:PrivatePlacementMember2021-02-232021-02-230001839550faca:PrivatePlacementWarrantMemberus-gaap:PrivatePlacementMember2021-02-230001839550faca:PrivatePlacementWarrantMemberus-gaap:CommonClassAMemberus-gaap:PrivatePlacementMember2022-06-300001839550faca:PrivatePlacementWarrantMemberus-gaap:PrivatePlacementMember2022-06-300001839550us-gaap:PrivatePlacementMemberfaca:PrivatePlacementWarrantMember2022-01-012022-06-300001839550us-gaap:InvestorMemberus-gaap:CommonClassBMember2021-01-312021-01-310001839550us-gaap:CommonClassBMemberus-gaap:InvestorMember2020-12-312020-12-310001839550faca:CommonClassLMemberus-gaap:InvestorMember2021-01-312021-01-310001839550faca:CommonClassLMemberus-gaap:InvestorMember2020-12-012020-12-310001839550faca:Director3Memberus-gaap:CommonClassBMember2021-02-122021-02-120001839550us-gaap:CommonClassBMemberfaca:Director1Member2021-02-122021-02-120001839550faca:Director2Memberus-gaap:CommonClassBMember2021-02-122021-02-120001839550us-gaap:InvestorMember2020-12-012020-12-310001839550us-gaap:InvestorMemberfaca:CommonClassLMember2020-12-310001839550us-gaap:CommonClassBMembersrt:MaximumMemberus-gaap:InvestorMember2021-01-310001839550us-gaap:InvestorMembersrt:MaximumMemberfaca:CommonClassLMember2021-01-310001839550us-gaap:CommonClassBMemberus-gaap:InvestorMember2021-02-230001839550faca:CommonClassLMemberus-gaap:InvestorMember2021-02-230001839550us-gaap:InvestorMemberus-gaap:CommonClassAMember2022-01-012022-06-300001839550us-gaap:CommonClassAMembersrt:MinimumMember2022-06-300001839550us-gaap:CommonClassAMembersrt:MinimumMember2022-01-012022-06-300001839550faca:PromissoryNoteMemberus-gaap:InvestorMember2020-12-220001839550faca:PromissoryNoteMember2021-02-230001839550faca:WorkingCapitalLoansMemberfaca:SponsorAffiliateOfSponsorOrCertainCompanyOfficersAndDirectorsMembersrt:MaximumMember2022-01-012022-06-300001839550faca:SponsorAffiliateOfSponsorOrCertainCompanyOfficersAndDirectorsMemberfaca:WorkingCapitalLoansMember2022-06-300001839550us-gaap:InvestorMember2021-12-310001839550us-gaap:InvestorMember2022-06-300001839550us-gaap:OverAllotmentOptionMember2021-02-232021-02-230001839550faca:CommonClassLMemberus-gaap:InvestorMember2021-12-310001839550faca:CommonClassLMemberus-gaap:InvestorMember2021-01-310001839550faca:CommonClassLMemberfaca:ShareBasedPaymentArrangementTrancheFourMember2022-06-300001839550us-gaap:ShareBasedCompensationAwardTrancheTwoMemberfaca:CommonClassLMember2022-06-300001839550us-gaap:InvestorMembersrt:MinimumMemberus-gaap:CommonClassAMember2022-06-300001839550us-gaap:ShareBasedCompensationAwardTrancheOneMemberfaca:CommonClassLMember2022-06-300001839550faca:CommonClassLMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2022-06-300001839550us-gaap:InvestorMemberus-gaap:CommonClassAMembersrt:MinimumMember2022-01-012022-06-300001839550us-gaap:InvestorMemberfaca:CommonClassLMember2020-12-312020-12-310001839550us-gaap:ShareBasedCompensationAwardTrancheOneMember2022-01-012022-06-300001839550us-gaap:ShareBasedCompensationAwardTrancheTwoMember2022-01-012022-06-300001839550us-gaap:FairValueMeasurementsRecurringMemberfaca:RedeemableWarrantsMemberus-gaap:FairValueInputsLevel3Member2021-12-310001839550faca:RedeemableWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001839550us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310001839550us-gaap:FairValueMeasurementsRecurringMemberfaca:RedeemableWarrantsMember2021-12-310001839550us-gaap:FairValueInputsLevel1Memberfaca:PrivatePlacementWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001839550us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-06-300001839550us-gaap:FairValueInputsLevel3Memberfaca:RedeemableWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001839550us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-12-310001839550us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberfaca:RedeemableWarrantsMember2021-12-310001839550us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001839550us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001839550us-gaap:FairValueMeasurementsRecurringMember2022-06-300001839550faca:RedeemableWarrantsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001839550us-gaap:FairValueMeasurementsRecurringMemberfaca:PrivatePlacementWarrantsMember2021-12-310001839550us-gaap:FairValueInputsLevel2Memberfaca:RedeemableWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001839550us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberfaca:PrivatePlacementWarrantsMember2022-06-300001839550faca:PrivatePlacementWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001839550faca:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001839550us-gaap:FairValueMeasurementsRecurringMemberfaca:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Member2022-06-300001839550us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-06-300001839550faca:PrivatePlacementWarrantsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-12-310001839550us-gaap:FairValueMeasurementsRecurringMember2021-12-310001839550us-gaap:FairValueMeasurementsRecurringMemberfaca:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Member2021-12-310001839550faca:RedeemableWarrantsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-12-310001839550faca:RedeemableWarrantsMember2021-02-230001839550faca:PrivatePlacementWarrantMember2021-02-230001839550us-gaap:WarrantMember2020-12-310001839550us-gaap:WarrantMember2021-01-012021-03-310001839550us-gaap:WarrantMember2021-04-012021-06-300001839550us-gaap:FairValueInputsLevel1Memberus-gaap:WarrantMember2021-04-012021-06-300001839550us-gaap:FairValueInputsLevel2Memberus-gaap:WarrantMember2021-04-012021-06-300001839550us-gaap:WarrantMember2021-06-300001839550us-gaap:WarrantMember2021-03-310001839550us-gaap:USTreasuryBillSecuritiesMember2021-12-310001839550us-gaap:USTreasuryBillSecuritiesMember2022-06-30xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:purefaca:Directorfaca:Demandfaca:Tranchefaca:Vote

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒	Quarterly Report PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2022

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___ to ___

Commission File Number 001-40081

Figure Acquisition Corp. I

(Exact Name of Registrant as Specified in Its Charter)

Delaware		85-4326385
(State or Other Jurisdiction of Incorporation or Organization)		(I.R.S. Employer Identification No.)

650 California Street, Suite 2700 San Francisco, CA		94108
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s telephone number, including area code: +1 628-210-6937

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class	Trading Symbol(s)	Name of Each Exchange on Which Registered
Class A common stock, par value $0.01 per share	FACA	The New York Stock Exchange
Redeemable warrants, each one whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50	FACA WS	The New York Stock Exchange
Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant	FACA.U	The New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

	Large accelerated filer ☐	Accelerated filer ☐
	Non-accelerated filer ☒	Smaller reporting company ☒
	Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

As of August 15, 2022, 28,750,000 shares of Class A common stock, par value $0.01 per share, 3,194,444 shares of Class B common stock, par value $0.0001 per share and 9,126,984 shares of Class L common stock, par value $0.0001 per share were issued and outstanding, respectively.

FIGURE ACQUISITION CORP. I

Form 10-Q

For the Quarter Ended June 30, 2022

Table of Contents

	Page
PART I. FINANCIAL INFORMATION	1
Item 1. Financial Statements	1
Condensed Balance Sheets as of June 30, 2022 (Unaudited) and December 31, 2021	1
Unaudited Condensed Statements of Operations for the three and six months ended June 30, 2022 and June 30, 2021	2
Unaudited Condensed Statements of Changes in Stockholders’ Deficit for the three and six months ended June 30, 2022 and June 30, 2021	3
Unaudited Condensed Statements of Cash Flows for the six months ended June 30, 2022 and June 30, 2021	4
Notes to Condensed Financial Statements (Unaudited)	5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.	22
Item 3. Quantitative and Qualitative Disclosures About Market Risk.	26
Item 4. Controls and Procedures.	26
PART II - OTHER INFORMATION	27
Item 1. Legal Proceedings.	27
Item 1A. Risk Factors.	27
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.	28
Item 3. Defaults Upon Senior Securities.	29
Item 4. Mine Safety Disclosures.	29
Item 5. Other Information.	29
Item 6. Exhibits.	30
Signatures	31

Table of Contents

FIGURE ACQUISITION CORP. I

CONDENSED BALANCE SHEETS

	June 30, 2022 (Unaudited)			December 31, 2021
Assets:
Current assets:
Cash	$	167,228		$	769,595
Prepaid Expenses		239,788			296,843
Total current assets		407,016			1,066,438
Cash and marketable securities held in Trust Account		287,967,734			287,549,179
Other non-current assets		—			39,850
Total Assets	$	288,374,750		$	288,655,467

Liabilities, Redeemable Common Stock and Stockholders’ Deficit
Current liabilities:
Accounts payable, accrued offering costs and expenses	$	327,212		$	317,099
Income taxes payable		1,106			—
Total current liabilities		328,318			317,099
Deferred underwriting fee		10,062,500			10,062,500
Warrant liability		2,223,750			14,454,374
Total liabilities		12,614,568			24,833,973

Commitments and Contingencies (See Note 6)

Class A Common Stock subject to possible redemption; 28,750,000 shares at redemption value at June 30, 2022 and December 31, 2021		287,748,505			287,500,000

Stockholders’ Deficit:
Preferred stock, $0.0001 par value; 1,000,000 shares authorized;none issued and outstanding		—			—
Class A common stock, $0.01 par value; 100,000,000 shares authorized; no shares issued and outstanding (excluding 28,750,000 shares subject to possible redemption) at June 30, 2022 and December 31, 2021		—			—
Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 3,194,444 shares issued and outstanding at June 30, 2022 and December 31, 2021		319			319
Class L common stock, $0.0001 par value; 15,000,000 shares authorized; 9,126,984 shares issued and outstanding at June 30, 2022 and December 31, 2021		913			913
Additional paid-in capital		—			—
Accumulated deficit		(11,989,555	)		(23,679,738	)
Total stockholders’ deficit		(11,988,323	)		(23,678,506	)
Total Liabilities, Redeemable Common Stock and Stockholders’ Deficit	$	288,374,750		$	288,655,467

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

FIGURE ACQUISITION CORP. I

CONDENSED STATEMENTS OF OPERATIONS

(UNAUDITED)

	For the three months ended June 30,						For the six months ended June 30,
	2022			2021			2022			2021
Formation and operating costs	$	398,571		$	228,083		$	788,509		$	319,206
Loss from operations		(398,571	)		(228,083	)		(788,509	)		(319,206	)

Other income (loss):
Interest earned on cash and marketable securities held in Trust Account		438,679			3,492			497,679			3,492
Offering costs allocated to warrants		—			—			—			(621,678	)
Fair value of private warrants in excess of proceeds received		—			—			—			(155,000	)
Change in fair value of warrant liability		6,547,708			(864,791	)		12,230,624			1,853,125
Total other income (loss), net		6,986,387			(861,299	)		12,728,303			1,079,939

Income before provision for income taxes		6,587,816			—			11,939,794			—
Provision for income taxes		1,106			—			1,106			—

Net income (loss)	$	6,586,710		$	(1,089,382	)	$	11,938,688		$	760,733

Weighted average shares outstanding, Class A common stock subject to possible redemption		28,750,000			28,750,000			28,750,000			20,331,492
Basic and diluted net income (loss) per share, Class A common stock subject to possible redemption	$	0.16		$	(0.03	)	$	0.29		$	0.02
Weighted average shares outstanding, Non-redeemable Class B common stock		3,194,444			3,194,444			3,194,444			3,072,437
Basic and diluted net income (loss) per share, Non-redeemable Class B common stock	$	0.16		$	(0.03	)	$	0.29		$	0.02
Weighted average shares outstanding, Non-redeemable Class L common stock		9,126,984			9,126,984			9,126,984			8,778,392
Basic and diluted net income (loss) per share, Non-redeemable Class L common stock	$	0.16		$	(0.03	)	$	0.29		$	0.02

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

FIGURE ACQUISITION CORP. I

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

(UNAUDITED)

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2022

	Class A Common stock				Class B Common stock				Class L Common stock				Additional Paid-in		Accumulated			Total Stockholder’s
	Shares		Amount		Shares		Amount		Shares		Amount		Capital		Deficit			Deficit
Balance as of January 1, 2022		—	$	—		3,194,444	$	319		9,126,984	$	913	$	—	$	(23,679,738	)	$	(23,678,506	)
Net income		—		—		—		—		—		—		—		5,351,978			5,351,978
Balance as of March 31, 2022		—		—		3,194,444		319		9,126,984		913		—		(18,327,760	)		(18,326,528	)
Accretion of Class A common stock subject to possible redemption to redemption value		—		—		—		—		—		—		—		(248,505	)		(248,505	)
Net income		—		—		—		—		—		—		—		6,586,710			6,586,710
Balance as of June 30, 2022		—	$	—		3,194,444	$	319		9,126,984	$	913	$	—	$	(11,989,555	)	$	(11,988,323	)

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2021

	Class A Common stock				Class B Common stock				Class L Common stock				Additional Paid-in			Accumulated			Total Stockholder’s
	Shares		Amount		Shares		Amount		Shares		Amount		Capital			Deficit			Equity (Deficit)
Balance as of January 1, 2021		—	$	—		3,194,444	$	319		9,126,984	$	913	$	23,768		$	(8,134	)	$	16,866
Net income		—		—		—		—		—		—		—			1,850,115			1,850,115
Remeasurement of Class A common stock subject to possible redemption		—		—		—		—		—		—		(23,768	)		(26,604,441	)		(26,628,209	)
Balance as of March 31, 2021		—		—		3,194,444		319		9,126,984		913		—			(24,762,460	)		(24,761,228	)
Net loss		—		—		—		—		—		—		—			(1,089,382	)		(1,089,382	)
Accretion of Class A common stock subject to possible redemption to redemption value		—		—		—		—		—		—		—			(3,492	)		(3,492	)
Balance as of June 30, 2021		—	$	—		3,194,444	$	319		9,126,984	$	913	$	—		$	(25,855,334	)	$	(25,854,102	)

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

FIGURE ACQUISITION CORP. I

CONDENSED STATEMENTS OF CASH FLOWS

(UNAUDITED)

	For the six months ended June 30,
	2022			2021
Cash flows from Operating Activities:
Net income	$	11,938,688		$	760,733
Adjustments to reconcile net income to net cash used in operating activities:
Interest earned on cash and marketable securities held in Trust Account		(497,679	)		(3,492	)
Offering costs allocated to warrants		—			621,678
Fair value of private warrants in excess of proceeds received		—			155,000
Change in fair value of warrant liability		(12,230,624	)		(1,853,125	)
Changes in operating assets and liabilities:
Prepaid expenses		57,055			(315,883	)
Other non-current assets		39,850			(189,492	)
Accounts payable, accrued offering costs and expenses		10,113			165,649
Income taxes payable		1,106			—
Due to related parties		—			60,361
Net cash used in operating activities		(681,491	)		(598,571	)

Cash Flows from Investing Activities:
Investment of cash in Trust Account		—			(287,500,000	)
Cash withdrawn from Trust Account for franchise taxes		79,124			—
Net cash provided by (used in) investing activities		79,124			(287,500,000	)

Cash flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discount		—			281,750,000
Proceeds from issuance of Private Placement Warrants		—			7,750,000
Proceeds from promissory note – related party		—			115,492
Repayment of promissory note – related party		—			(115,492	)
Advances from related party		354,015			—
Repayment of advances from related party		(354,015	)		—
Payment of offering costs		—			(440,512	)
Net cash provided by financing activities		—			289,059,488

Net change in cash		(602,367	)		960,917
Cash, beginning of the period		769,595			25,000
Cash, end of the period	$	167,228		$	985,917

Supplemental disclosure of non-cash investing and financing activities:
Deferred underwriters’ discount payable charged to additional paid-in capital	$	—		$	10,062,500
Initial classification of warrant liability	$	—		$	18,901,875
Initial classification of common stock subject to possible redemption	$	—		$	287,500,000
Accretion of Class A common stock subject to possible redemption to redemption value	$	248,505		$	3,492

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

FIGURE ACQUISITION CORP. I
NOTES TO CONDENSED FINANCIAL STATEMENTS

JUNE 30, 2022

(UNAUDITED)

Note 1 — Organization and Business Operations

Figure Acquisition Corp. I (the “Company”) is a blank check company incorporated as a Delaware corporation on December 15, 2020. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (“Business Combination”).

As of June 30, 2022, the Company had not commenced any operations. All activity through June 30, 2022 relates to the Company’s formation and the initial public offering (the “IPO” or the “Initial Public Offering”) which is described below, and after completion of the IPO, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering, and other income (loss) from the change in fair value of the warrant liability.

The registration statement for the Company’s IPO was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on February 18, 2021 (the “Effective Date”). On February 23, 2021, the Company consummated the IPO of 28,750,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units sold, the “Public Shares”), which included the full exercise by the underwriters of the over-allotment option to purchase an additional 3,750,000 Units, at $10.00 per Unit, generating gross proceeds of $287,500,000, which is discussed in Note 3. Each Unit consists of one share of common stock, and one-fourth of one redeemable warrant to purchase one share of Class A common stock at a price of $11.50 per whole share.

Simultaneously with the closing of the IPO, the Company consummated the sale of 5,166,667 Private Placement Warrants (the “Private Placement Warrants”), at a price of $1.50 per Private Placement Warrant, in a private placement to Fintech Acquisition LLC, a Delaware limited liability company (the “Sponsor”), generating gross proceeds of $7,750,000, which is discussed in Note 4.

Transaction costs of the IPO amounted to $16,253,012 consisting of $5,750,000 of underwriting discount, $10,062,500 of deferred underwriting discount, and $440,512 of other offering costs, and of which $621,678 were allocated to expense associated with the warrant liability.

Following the closing of the IPO on February 23, 2021, $287,500,000 ($10.00 per Unit) from the net offering proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”) and invested in U.S. government treasury bills with a maturity of 185 days or less or in money market funds investing solely in U.S. Treasuries, as determined by the Company, until the earlier of: (a) the completion of the Company’s initial Business Combination, (b) the redemption of any shares of the Company’s Public Shares properly submitted in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation (i) to modify the substance or timing of the Company’s obligation to provide for the redemption of the Public Shares in connection with the initial Business Combination or to redeem 100% of the Company’s Public Shares if it does not complete its initial Business Combination within 24 months from the closing of the IPO or (ii) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity, and (c) the redemption of 100% of the Company’s public shares if the Company is unable to complete the initial Business Combination within 24 months from the closing of the IPO, subject to applicable law.

Table of Contents

The Company will provide its public stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination either (i) in connection with a stockholder meeting called to approve the initial Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a proposed initial Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem their shares for a pro rata share of the aggregate amount then on deposit in the Trust Account (initially approximately $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations).

The Company will have 24 months from February 23, 2021, the closing of the IPO, to complete an initial Business Combination (the “Combination Period”). However, if the Company is unable to complete its initial Business Combination within the Combination Period, the Company will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.

The Sponsor, officers and directors have agreed to (i) waive their redemption rights with respect to their shares of the Company’s Class B common stock (the “founder shares”), shares of Class L common stock and public shares in connection with the completion of the initial Business Combination, (ii) waive their redemption rights with respect to their founder shares, shares of Class L common stock and public shares in connection with a stockholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation (A) to modify the substance or timing of the Company’s obligation to provide for the redemption of the public shares in connection with an initial Business Combination or to redeem 100% of the public shares if the Company does not complete the initial Business Combination within the Combination Period or (B) with respect to any other material provisions relating to stockholder’s rights or pre-initial Business Combination activity, (iii) waive their rights to liquidating distributions from the Trust Account with respect to their founder shares and shares of Class L common stock if the Company fails to complete the initial Business Combination within the Combination Period, and (iv) vote any founder shares held by them and any public shares purchased during or after the Public Offering (including in open market and privately-negotiated transactions) in favor of the Company’s initial Business Combination.

The Company’s Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable), nor will it apply to any claims under the Company’s indemnity of the underwriters of the Public Offering against certain liabilities, including liabilities under the Securities Act. However, the Company has not asked its Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether its Sponsor has sufficient funds to satisfy its indemnity obligations and believes that the Company’s Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure that its Sponsor would be able to satisfy those obligations.

Liquidity, Capital Resources, and Going Concern

As of June 30, 2022 and December 31, 2021, the Company had approximately $0.2 million and $0.8 million in its operating bank account, respectively, and working capital of approximately $0.3 million and $0.7 million, respectively, net of franchise and income taxes payable and taxes paid out of operating funds not yet reimbursed by the Trust, as applicable, of approximately $0.2 million and $0.7 million, respectively.

Table of Contents

The Company’s liquidity needs up to February 23, 2021 had been satisfied through a capital contribution from the Sponsor of $25,000 (see Note 5) for the Founder shares and Class L shares, and the loan under an unsecured promissory note from the Sponsor of up to $300,000 which was paid in full on February 23, 2021 from the IPO proceeds (see Note 5), and advances from an affiliate of the Sponsor of $354,015 (which were repaid) (see Note 5).

Subsequent to the consummation of the IPO, the Company’s liquidity needs have been satisfied through the net proceeds from the consummation of the Private Placement not held in the Trust Account. In order to finance transaction costs in connection with a Business Combination, our Sponsor or certain of our officers and directors may, but are not obligated to, provide us working capital loans. Additionally, an affiliate of the Company’s Sponsor entered into a commitment letter with the Company whereby the affiliate of the Company’s Sponsor agreed to provide working capital loans sufficient for the Company to satisfy its obligation as they come due until the earlier of: (a) the completion of the initial Business Combination, or (b) liquidation. Any such working capital loan under the commitment letter will be repaid to the affiliate of the Company’s Sponsor by the Company upon the completion of the initial Business Combination or, in the event of liquidation prior to the completion of the initial Business Combination, forgiven by the affiliate of the Company’s Sponsor upon liquidation. As of June 30, 2022 and December 31, 2021, there were no amounts outstanding under any working capital loan.

If the Company does not consummate an initial business combination by February 23, 2023, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the mandatory liquidation, should an initial business combination not occur, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. The Company intends to consummate an initial business combination prior to February 23, 2023; however, it is uncertain whether the Company will be able to do so. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Other Risks and Uncertainties

Management is continuing to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that it could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these unaudited condensed financial statements. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.

In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these unaudited condensed financial statements and the specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these unaudited condensed financial statements.

Note 2 — Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed financial statements of the Company are presented in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented.

Table of Contents

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 as filed with the SEC on April 13, 2022, which contains the audited financial statements and notes thereto. The accompanying condensed balance sheet as of December 31, 2021 has been derived from the audited financial statements. The interim results for the three and six months ended June 30, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or for any future interim periods.

Emerging Growth Company Status

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of unaudited condensed financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

Out-of-Period Adjustment

During the second quarter of 2022, the Company determined that it had not recognized certain filing and listing fees related to the year ended December 31, 2021. The Company assessed these errors and determined that they were not material to previous reporting periods. Therefore, the Company recorded these items as out-of-period adjustments in the three and six months ended June 30, 2022 by increasing formation and operating costs by $158,128 in the Condensed Statements of Operations.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2022 and December 31, 2021.

Table of Contents

Marketable Securities Held in Trust Account

At June 30, 2022 and December 31, 2021, the assets held in the Trust Account were held primarily in U.S. Treasury Bills with maturities of 185 days or less. During the six months ended June 30, 2022, the Company withdrew $79,124 of the interest income from the Trust Account to pay its tax obligations.

The Company classifies its United States Treasury securities as held-to-maturity in accordance with FASB ASC Topic 320, “Investments - Debt and Equity Securities.” Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost and adjusted for the amortization or accretion of premiums or discounts.

A decline in the market value of held-to-maturity securities below cost that is deemed to be other than temporary, results in an impairment that reduces the carrying costs to such securities’ fair value. The impairment is charged to earnings and a new cost basis for the security is established. To determine whether an impairment is other than temporary, the Company considers whether it has the ability and intent to hold the investment until a market price recovery and considers whether evidence indicating the cost of the investment is recoverable outweighs evidence to the contrary. Evidence considered in this assessment includes the reasons for the impairment, the severity and the duration of the impairment, changes in value subsequent to year-end, forecasted performance of the investee, and the general market condition in the geographic area or industry in which the investee operates.

Premiums and discounts are amortized or accreted over the life of the related held-to-maturity security as an adjustment to yield using the effective-interest method. Such amortization and accretion are included in the “interest earned on cash and marketable securities held in Trust Account” line item in the condensed statements of operations. Interest income is recognized when earned.

Warrant Liabilities

The Company evaluated the Public Warrants and Private Placement Warrants (collectively, “Warrants”, which are discussed in Note 3, Note 4 and Note 8) in accordance with ACS 480, “Distinguishing Liabilities from Equity” and ASC 815-40, “Derivatives and Hedging — Contracts in Entity’s Own Equity”, and concluded that a provision in the Warrant Agreement related to certain tender or exchange offers precludes the Warrants from being accounted for as components of equity. As the Warrants meet the definition of a derivative as contemplated in ASC 815, the Warrants are recorded as derivative liabilities on the Condensed Balance Sheets and measured at fair value at inception (on the date of the IPO) and at each reporting date in accordance with ASC 820, “Fair Value Measurement”, with changes in fair value recognized in the Condensed Statements of Operations in the period of change.

Offering Costs Associated with the Initial Public Offering

The Company complies with the requirements of ASC 340-10-S99-1. Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred and presented as non-operating expenses in the condensed statements of operations. Offering costs associated with the Class A common stock were charged to temporary equity upon the completion of the Initial Public Offering. Transaction costs amounted to $16,253,012, of which $621,678 were allocated to expense associated with the warrant liability.

Common Stock Subject to Possible Redemption

All of the Class A Common Stock sold as part of the Units in the Public Offering contain a redemption feature which allows for the redemption of such public shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s second amended and restated certificate of incorporation. In accordance with SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of the Company require common stock subject to redemption to be classified outside of permanent equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC 480. Accordingly, at June 30, 2022 and December 31, 2021, all shares of Class A common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ deficit section of the Company’s condensed balance sheets.

Table of Contents

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by charges against additional paid-in capital (to the extent available) and accumulated deficit. Subsequent to the IPO, accretion includes cumulative interest earned on cash and marketable securities held in the Trust account, net of amounts withdrawn to pay taxes and incurred taxes that are eligible to be reimbursed from the Trust account in the future.

At June 30, 2022 and December 31, 2021, the Class A common stock reflected in the condensed balance sheets are reconciled in the following table:

Gross Proceeds	$	287,500,000
Less:
Proceeds allocated to Public Warrants		(10,996,875	)
Issuance costs related to Class A ordinary shares		(16,253,262	)
Plus:
Offering costs allocated to warrants		621,678
Remeasurement of Class A common stock to redemption value		26,628,459
Class A common stock subject to possible redemption, December 31, 2021		287,500,000
Plus:
Accretion of Class A common stock to redemption value		248,505
Class A common stock subject to possible redemption, June 30, 2022	$	287,748,505

Share-Based Compensation

The Company complies with ASC Topic 718, “Compensation - Stock Compensation” regarding interests in founder shares transferred by the Sponsor to directors of the Company as compensation, which are described in Note 5.

The interests in the Founder Shares effectively vest upon the Company completing the initial Business Combination and compensation expense will be recorded accordingly at that date based upon the initial grant date fair value, the determination of which represents a significant estimate. The grant date fair value is based upon an option pricing model.

The Founders Shares were granted subject to a performance condition (i.e., consummation of the Business Combination). Compensation expense related to the Founders Shares will be recognized only when the performance condition is probable of occurrence under the applicable accounting literature in this circumstance.

As of June 30, 2022 and December 31, 2021, the Company determined that a Business Combination is not considered probable, and therefore no stock-based compensation expense has been recognized. Stock-based compensation will be recognized at the date a Business Combination is considered probable (i.e., upon completion of a Business Combination) in an amount equal to the number of Founders Shares that ultimately vest multiplied times the grant date fair value per share (unless subsequently modified) less the amount initially received for the purchase of the Founders Shares.

Table of Contents

Income Taxes

The Company is included in the consolidated tax return of Figure Technologies, Inc (the “Parent”). The Company calculates the provision for income taxes by using a “separate return” method. Under this method the Company is assumed to file a separate return with the tax authority, thereby reporting its taxable income or loss and paying the applicable tax to, or receiving the appropriate refund from, the Parent. The Company’s current provision is the amount of tax payable or refundable on the basis of a hypothetical, current year, separate return.

The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740, Income Taxes, requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the unaudited condensed financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. ASC 740-270-25-2 requires that an annual effective tax rate be determined and such annual effective rate applied to year to date income in interim periods under ASC 740-270-30-5. As of June 30, 2022 and December 31, 2021, the Company’s deferred tax asset had a full valuation allowance recorded against it. Our effective tax rate was 0.02% and 0.00% for the three months ended June 30, 2022 and 2021, respectively, and 0.01% and 0.00% for the six months ended June 30, 2022 and 2021, respectively. The effective tax rate differs from the statutory tax rate of 21% for the three and six months ended June 30, 2022 and 2021, due to changes in fair value of the warrant liabilities, which are not recognized for income tax purposes, and the valuation allowance on the deferred tax assets.

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.

The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

Net Income (Loss) Per Share of Common Stock

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, Earnings Per Share. Basic and diluted net income (loss) per share of common stock, for each respective class of common stock, is computed by dividing net income (loss) by the weighted average number of shares of each respective class of common stock outstanding during the period, allocated proportionally to each class of common stock. The Company has three classes of stock, redeemable Class A Common Stock, non-redeemable Class B Common Stock and non-redeemable Class L Common Stock. Earnings and losses are shared pro rata between the Class A, Class B and Class L Common Stock. The Company has not considered the effect of warrants sold in the Initial Public Offering and the private placement to purchase an aggregate of 12,354,167 shares of common stock in the calculation of diluted income (loss) per share of stock, since the exercise of the warrants is contingent upon the occurrence of future events. As a result, diluted net income (loss) per share of common stock is the same as basic net income (loss) per share of common stock for the periods presented. Remeasurement associated with the redeemable shares of Class A common stock is excluded from income (loss) per share of common stock as the redemption value approximates fair value.

Reconciliation of Net Income (Loss) per Share of Common Stock

The Company’s net income (loss) is adjusted for the portion of net income (loss) that is allocable to each class of common stock. The allocable net income (loss) is calculated by multiplying net income (loss) by the ratio of weighted average number of shares outstanding attributable to Class A, Class B and Class L common stock to the total weighted average number of shares outstanding for the period. Accordingly, basic and diluted income (loss) per share of common stock is calculated as follows:

Table of Contents

	Three Months Ended June 30,					Six Months Ended June 30,
	2022		2021			2022		2021
Redeemable Class A Common Stock
Numerator: Net income (loss) allocable to Class A Common Stock	$	4,610,697	$	(762,567	)	$	8,357,082	$	480,600
Denominator: Basic and diluted weighted average shares outstanding, Class A common stock		28,750,000		28,750,000			28,750,000		20,331,492
Basic and diluted net income (loss) per share of common stock	$	0.16	$	(0.03	)	$	0.29	$	0.02

Non-Redeemable Class B Common Stock
Numerator: Net income (loss) allocable to Non-Redeemable Stock	$	512,300	$	(84,730	)	$	928,565	$	72,627
Denominator: Weighted Average Non-Redeemable stock
Basic and diluted weighted average shares outstanding		3,194,444		3,194,444			3,194,444		3,072,437
Basic and diluted net income (loss) per share of common stock	$	0.16	$	(0.03	)	$	0.29	$	0.02

Non-Redeemable Class L Common Stock
Numerator: Net income (loss) allocable to Non-Redeemable Stock	$	1,463,713	$	(242,085	)	$	2,653,042	$	207,506
Denominator: Weighted Average Non-Redeemable stock
Basic and diluted weighted average shares outstanding		9,126,984		9,126,984			9,126,984		8,778,392
Basic and diluted net income (loss) per share of common stock	$	0.16	$	(0.03	)	$	0.29	$	0.02

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature.

Recent Accounting Pronouncements

In August 2020, the FASB issued ASU 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. ASU 2020-06 also removes certain settlement conditions that are required for equity-linked contracts to qualify for scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company early adopted ASU 2020-06 on January 1, 2021. Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows.

Management does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

Table of Contents

Note 3 — Initial Public Offering

Public Units

On February 23, 2021, the Company sold 28,750,000 Units, at a purchase price of $10.00 per Unit, which included the full exercise by the underwriters of the over-allotment option to purchase an additional 3,750,000 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one share of Class A common stock, and one-fourth of one redeemable warrant to purchase one share of Class A common stock (the “Public Warrants”).

Public Warrants

Each whole Public Warrant entitles the holder to purchase one share of the Company’s Class A common stock at a price of $11.50 per share, subject to adjustment as discussed herein. The warrants will become exercisable on the later of 12 months from February 23, 2021, the closing of the Public Offering, or 30 days after the completion of the initial Business Combination, and will expire five years after the completion of the Company’s initial Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.

In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, (i) in the case of any such issuance to the Sponsor or any of its respective affiliates, without taking into account any founder shares or shares of Class L common stock held by the Sponsor or such affiliates, as applicable, prior to such issuance, and (ii) to the extent that such issuance is made to the Sponsor or any of its respective affiliates, without taking into account the transfer of founder shares, shares of Class L common stock or private placement warrants by the Sponsor in connection with such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described below in “Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00” and “Redemption of warrants when the price per share of Class A common stock equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger described below in “Redemption of warrants when the price per share of Class A common stock equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.

The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the shares of Class A common stock underlying the warrants is then effective and a prospectus relating thereto is current. No warrant will be exercisable and the Company will not be obligated to issue shares of Class A common stock upon exercise of a warrant unless Class A common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. In no event will the Company be required to net cash settle any warrant. In the event that a registration statement is not effective for the exercised warrants, the purchaser of a unit containing such warrant will have paid the full purchase price for the unit solely for the share of Class A common stock underlying such unit.

Table of Contents

Redemption of Warrants When the Price per Share of Class A Common Stock Equals or Exceeds $18.00

Once the warrants become exercisable, the Company may redeem the outstanding warrants:

●

in whole and not in part;

●

at a price of $0.01 per warrant;

●

upon not less than 30 days’ prior written notice of redemption (the “30-day redemption period”); and

●

if, and only if, the last reported sale price of the Class A common stock for any 20 trading days within a 30-trading day period ending three trading days before we send the notice of redemption to the warrant holders (which we refer to as the “Reference Value”) equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and certain issuances of Class A common stock and equity-linked securities).

The Company will not redeem the warrants as described above unless a registration statement under the Securities Act covering the issuance of the Class A common stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class A common stock is available throughout the 30-day redemption period. If and when the warrants become redeemable, the Company may exercise its redemption right even if unable to register or qualify the underlying securities for sale under all applicable state securities laws.

Redemption of Warrants When the Price per Share of Class A Common Stock Equals or Exceeds $10.00

Once the warrants become exercisable, the Company may redeem the outstanding warrants:

●

in whole and not in part;

●

at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption, provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the “fair market value” of the Class A common stock (as defined below in the immediately following paragraph) except as otherwise described below;

●

if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted per stock splits, stock dividends, reorganizations, recapitalizations and the like and certain issuances of Class A common stock and equity-linked securities); and

●

if the Reference Value is less than $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and certain issuances of Class A common stock and equity-linked securities), the private placement warrants must also be concurrently called for redemption on the same terms as the outstanding public warrants, as described above.

The “fair market value” of the Class A common stock for the above purpose shall mean the volume-weighted average price of the Class A common stock as reported during the ten trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. The Company will provide our warrant holders with the final fair market value no later than one business day after the ten-trading day period described above ends. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 shares of Class A common stock per whole warrant (subject to adjustment).

Table of Contents

If a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants is not effective by the 60th business day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. In such event, each holder would pay the exercise price by surrendering the warrants for that number of shares of Class A common stock equal to the lesser of (A) the quotient obtained by dividing (x) the product of the number of shares of Class A common stock underlying the warrants, multiplied by the excess of the “fair market value” of the Class A common stock over the exercise price of the warrants by (y) the fair market value and (B) 0.361 per whole warrant. The “fair market value” as used in this paragraph shall mean the average last reported sale price of the Class A common stock for the ten trading days ending on the third trading day prior to the date on which the notice of exercise is received by the warrant agent. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis.

Note 4 — Private Placement

Simultaneously with the closing of the IPO, the Sponsor purchased an aggregate of 5,166,667 Private Placement Warrants at a price of $1.50 per Private Placement Warrant, for an aggregate purchase price of $7,750,000, in a private placement. The fair value of a warrant at IPO was $1.53; the aggregate fair value of the warrants exceeded the proceeds received by $155,000 which was included in other income (loss) in the condensed statement of operations. Each whole Private Placement Warrant entitles the holder to purchase one share of the Company’s Class A common stock at a price of $11.50 per share, subject to adjustment as discussed herein. A portion of the proceeds from the private placement was added to the proceeds from the IPO held in the Trust. The Private Placement Warrants will be non-redeemable in certain circumstances and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees. Otherwise, the Private Placement Warrants have terms and provisions that are identical to those of the warrants being sold as part of the Units in the Public Offering.

The Private Placement Warrants are identical to the Public Warrants sold in the IPO except that the Private Placement Warrants, so long as they are held by the initial stockholders or its permitted transferees, (i) they will not be redeemable by the Company for cash, (ii) they (including the Class A common stock issuable upon exercise of these warrants) may not, subject to certain limited exceptions, be transferred, assigned or sold until 30 days after the completion of the Company’s initial Business Combination, and (iii) they may be exercised by the holders on a cashless basis. If the Private Placement Warrants are held by holders other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by the holders on the same basis as the warrants included in the Units being sold in the IPO.

Note 5 — Related Party Transactions

Founder Shares

In December 2020, the Company’s Sponsor purchased 4,107,143 shares of Class B common stock and 8,214,286 shares of Class L common stock for a capital contribution of $25,000, or approximately $0.002 per share. In January 2021, the Company’s Sponsor surrendered its Class B and Class L shares, and the Company reissued to the Sponsor 3,194,444 shares of Class B common stock (the “founder shares”) and 9,126,984 shares of Class L common stock, with no return of capital or payment by the Sponsor, resulting in the Sponsor holding 3,194,444 shares of Class B common stock and 9,126,984 shares of Class L common stock, including an aggregate of up to 416,667 shares of Class B common stock and up to 1,190,476 shares of Class L common stock subject to forfeiture, respectively, if the over-allotment option was not exercised by the underwriters in full. All shares of common stock and associated amounts have been retroactively restated. On February 12, 2021, our sponsor transferred 20,000 shares of Class B common stock to each of our three independent directors. As a result of the underwriters’ election to fully exercise their over-allotment option on February 23, 2021, none of the Class B shares or Class L shares are subject to forfeiture.

Table of Contents

With certain limited exceptions, the Founder shares and Class L shares are not transferable, assignable or saleable (except to the Company’s officers and directors and other persons or entities affiliated with the Sponsor, including their respective limited partners, each of whom will be subject to the same transfer restrictions) until the earlier of (A) one year after the completion of the Company’s initial Business Combination or (B) subsequent to the Company’s initial Business Combination, (x) if the reported closing price of Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Company’s initial Business Combination or (y) the date, following the completion of the Company’s initial Business Combination, on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property.

Promissory Note — Related Party

On December 22, 2020, Company issued an unsecured promissory note to the Sponsor for an aggregate of up to $300,000 to cover expenses related to the IPO. This loan was non-interest bearing and payable on the earlier of December 31, 2021 or the completion of the IPO. During the period from January 1, 2021 to February 23, 2021, the Company had borrowed $115,492 under the promissory note. On February 25, 2021, the Company paid the note balance in full from the proceeds of the IPO, and the note is no longer available to be drawn upon.

Related Party Loans

In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may loan the Company funds (“Working Capital Loans”), as discussed in Note 1. If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $2,000,000 of such Working Capital Loans may be convertible into warrants at a price of $1.50 per warrant at the option of the lender. The warrants would be identical to the Private Placement Warrants, including as to exercise price, exercisability and exercise period. At June 30, 2022 and December 31, 2021, no Working Capital Loans were outstanding.

Advance from Related Party

During the six months ended June 30, 2022, an affiliate of the Sponsor paid for expenses related to the Company in the amount of $354,015 which was repaid in full. There were no balances outstanding as an Advance from related party as of June 30, 2022 and December 31, 2021.

Note 6 — Commitments and Contingencies

Registration Rights

The Sponsor will have rights to require the Company to register any of its securities held by them for resale under the Securities Act pursuant to a registration and stockholder rights agreement to be signed prior to or on the effective date of the Public Offering. These holders will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities for sale under the Securities Act. In addition, the holders of the founder shares, Class L shares, Private Placement Warrants and warrants that may be issued upon conversion of working capital loans (and any shares of Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of working capital loans and upon conversion of the Founder shares and Class L shares) will have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act.

Table of Contents

Underwriting Agreement

The underwriter had a 45-day option from the date of the IPO to purchase up to an aggregate of 3,750,000 additional Units at the public offering price less the underwriting commissions to cover over-allotments, if any. On February 23, 2021, the underwriter fully exercised the over-allotment option, and was paid a fixed underwriting discount of 2% of the gross proceeds of the IPO, or $5,750,000 in aggregate.

The underwriters are entitled to a deferred underwriting fee of 3.5% of the gross proceeds of the IPO, or $10,062,500 in the aggregate which is included in the condensed balance sheets at June 30, 2022, and December 31, 2021. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

Note 7 — Stockholders’ Deficit

Preferred Stock — The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 and with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At June 30, 2022 and December 31, 2021, there were no shares of preferred stock issued or outstanding.

Class A Common Stock — The Company is authorized to issue a total of 100,000,000 shares of Class A common stock at par value of $0.01 each. At June 30, 2022 and December 31, 2021, there were no shares issued and outstanding, excluding 28,750,000 shares subject to possible redemption.

Class B Common Stock — The Company is authorized to issue a total of 10,000,000 shares of Class B common stock at par value of $0.0001 per share. At June 30, 2022 and December 31, 2021, there were 3,194,444 shares issued and outstanding.

The Company’s sponsor, directors and officers have agreed not to transfer, assign or sell their founder shares until the earlier to occur of (A) one year after the completion of the Company’s initial Business Combination or (B) subsequent to the Company’s initial Business Combination, (x) if the reported closing price of the Company’s Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Company’s initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange, or other similar transaction that results in all of its stockholders having the right to exchange their shares of common stock for cash, securities or other property.

The shares of Class B common stock will automatically convert into shares of the Company’s Class A common stock at the time of its initial Business Combination on a one-for-one basis, subject to adjustment pursuant to certain anti-dilution rights, as described herein. In the case that additional shares of Class A common stock or equity-linked securities are issued or deemed issued in connection with the Company’s initial Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 10% of the sum of (i) the total number of all shares of common stock outstanding upon the completion of the Public Offering, plus (ii) the total number of shares of Class A common stock and equity-linked securities issued or deemed issued in connection with or in connection with the initial Business Combination, excluding any shares of Class A common stock or equity-linked securities issued, or to be issued, to any seller in the initial business combination and any units or warrants issued to our sponsor or its affiliates upon conversion of Working Capital Loans; provided that such conversion of founder shares will never occur on a less than one for one basis.

Table of Contents

Prior to the initial Business Combination, only holders of the Company’s Class B common stock will have the right to vote on the election of directors. With respect to any other matter submitted to a vote of the Company’s stockholder, holders of record of the Class A common stock and holders of record of the Class B common stock will vote together as a single class, with each share of common stock entitling the holder to one vote except as required by law.

Class L Common Stock —The Company is authorized to issue a total of 15,000,000 shares of Class L common stock at par value of $0.0001 each. In December 2020, the Company issued 8,214,286 shares of Class L common stock to the Sponsor for approximately $0.002 per share. In January 2021, the Sponsor surrendered its Class L shares and the Company reissued 9,126,984 shares of Class L common stock to the Sponsor with no return of capital or payment by the Sponsor resulting in the Sponsor holding 9,126,984 shares of Class L common stock for approximately $0.002 per share. All shares of common stock and associated amounts have been retroactively restated. At June 30, 2022 and December 31, 2021, there were 9,126,984 shares issued and outstanding in stockholders’ deficit.

The Class L common stock shall have no voting rights and will convert into shares of Class A common stock following the initial Business Combination to the extent certain triggering vesting events occur. The Class L common stock will vest in four equal tranches upon achieving share performance targets. If between the consummation of our initial business combination and the ten year anniversary of the initial Business Combination the closing price of the Company’s Class A common stock equals or exceeds specified per share trading price targets for any 20 trading days within a 30-trading day period (the four vesting price targets equal $12.50 (“First Price Vesting”), $15.00 (“Second Price Vesting”), $17.50 (“Third Price Vesting”), and $20.00 (“Fourth Price Vesting”)), one-fourth of the Class L common stocks will automatically convert into Class A common stocks on a 1-for-1 basis. For example, if fifteen months following the consummation of the initial Business Combination the closing price of the shares of Class A common stock equals or exceeds $15.00 but does not exceed $17.50 for 20 trading days within a 30-trading day period, both the First Price Vesting and Second Price Vesting target achievements will be met, resulting in a total of 3,968,254 Class L Shares converting into 3,968,254 shares of Class A common stock, representing 1,984,127 shares associated with the First Price Vesting and 1,984,127 shares associated with the Second Price Vesting (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like).

For purposes of the foregoing price vesting targets, if the Company consummates any liquidation, merger, share exchange, reorganization or other similar transaction after its initial business combination and before the tenth anniversary of its initial business combination (a “Strategic Transaction”) which results in all of the public stockholders having the right to exchange their common stock for cash, securities or other property, then the Company’s board of directors will determine in good faith the effective price per share of Class A common stock in such Strategic Transaction. This effective price will dictate how many remaining shares of Class L common stock convert on a one-for-one basis to shares of Class A common stock, based on the foregoing price vesting targets.

For example, if the Company consummates a Strategic Transaction and the First and Second Price Vesting targets have previously been achieved and the effective price in such Strategic Transaction is determined to be $17.50, then 1,984,127 shares of Class L common stock will convert at the closing of such Strategic Transaction on a one-for-one basis to 1,984,127 shares of Class A common stock.

Further, for example, if the Company consummates a Strategic Transaction and the First and Second Price Vesting targets have previously not been achieved and the effective price in such Strategic Transaction is determined to be $17.50, then 5,952,381 shares of Class L common stock will convert at the closing of such Strategic Transaction on a one-for-one basis to 5,952,381 shares of Class A common stock.

Table of Contents

In contrast, if the Company consummates a Strategic Transaction and the First and Second Price Vesting targets have previously been achieved and the effective price in such Strategic Transaction is determined to be only $14.00, then under the Strategic Transaction threshold, no shares of Class L common stock will convert because no additional price vesting target has been achieved; thus, none of the remaining shares of Class L common stock will convert to shares of Class A common stock at the closing of such Strategic Transaction.

Note 8 — Fair Value Measurements

The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

Level 1 —

Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment.

Level 2 —

Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by market through correlation or other means.

Level 3 —

Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at June 30, 2022 and December 31, 2021, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

	June 30, 2022		Quoted Prices In Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Other Unobservable Inputs (Level 3)
Liabilities:
Public Warrant Liability	$	1,293,750	$	1,293,750	$	—	$	—
Private Placement Warrant Liability		930,000		—		930,000		—
Total	$	2,223,750	$	1,293,750	$	930,000	$	—

Table of Contents

	December 31, 2021		Quoted Prices In Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Other Unobservable Inputs (Level 3)
Liabilities:
Public Warrant Liability	$	8,409,374	$	8,409,374	$	—	$	—
Private Placement Warrant Liability		6,045,000		—		6,045,000		—
Total	$	14,454,374	$	8,409,374	$	6,045,000	$	—

The Warrants are accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the Condensed Balance Sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liability in the Condensed Statements of Operations.

The Company established the initial fair value of the Public Warrants and Private Warrants on February 23, 2021, the date of the Company’s Initial Public Offering, using a Monte Carlo simulation model. The Warrants were classified as Level 3 at the initial measurement date due to the use of unobservable inputs.

On February 23, 2021, the fair value of the Private Placement Warrants and Public Warrants was determined to be $1.53 per warrant. The following table presents the change in the fair value of Level 3 warrant liabilities for the three and six months ended June 30, 2021:

	Level 3 Warrant Liabilities
Fair Value as of December 31, 2020	$	—
Initial measurement on February 23, 2021		18,901,875
Change in valuation as of March 31, 2021		(2,717,916	)
Fair Value as of March 31, 2021		16,183,959
Change in valuation as of June 30, 2021		864,791
Transfer of Public Warrants to Level 1		(9,918,750	)
Transfer of Private Warrants to Level 2		(7,130,000	)
Fair Value as of June 30, 2021	$	—

Beginning with the quarter ended June 30, 2021, the Public Warrants were reclassified from Level 3 to Level 1 and the Private Placement Warrants were reclassified from Level 3 to Level 2, due to certain “make whole” provisions in the warrant agreement. As of June 30, 2022 and December 31, 2021 the Company used the quoted market price of the Public Warrants as the fair value of the Public Warrants and the Private Placement Warrants.

There were no transfers to/from Levels 1, 2 and 3 for the three and six months ended June 30, 2022.

Table of Contents

The carrying value, excluding gross unrealized holding gains (losses), fair value of held to maturity securities, and cash and cash equivalents, on June 30, 2022 and December 31, 2021, are as follows:

	Carrying Value as of June 30, 2022		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value as of June 30, 2022
U.S. Treasury Securities	$	287,966,946	$	—	$	(32,161	)	$	287,934,785
	$	287,966,946	$	—	$	(32,161	)	$	287,934,785

	Carrying Value as of December 31, 2021		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value as of December 31, 2021
U.S. Treasury Securities	$	287,548,366	$	2,435	$	—	$	287,550,801
	$	287,548,366	$	2,435	$	—	$	287,550,801

Note 9 — Subsequent Events

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the unaudited condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.

Table of Contents

ITEM 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

References to the “Company,” “Figure Acquisition Corp. I.,” “our,” “us” or “we” refer to Figure Acquisition Corp. I. The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act. We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other SEC filings.

Overview

We are a blank check company incorporated in Delaware on December 15, 2020. We were formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”).

Our Sponsor is Fintech Acquisition LLC, a Delaware limited liability company. The registration statement for the Initial Public Offering was declared effective on February 18, 2021. On February 23, 2021, we consummated the Initial Public Offering of 28,750,000 Units, at $10.00 per Unit, generating gross proceeds of $287.5 million, and incurring offering costs of approximately $16.3 million, inclusive of approximately $10.1 million in deferred underwriting commissions.

Simultaneously with the closing of the Initial Public Offering, we consummated the Private Placement of 5,166,667 Private Placement Warrants, at a price of $1.50 per Private Placement Warrant to our Sponsor, generating gross proceeds to us of approximately $7.75 million.

Upon the closing of the Initial Public Offering and the Private Placement, $287.5 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement was placed in the Trust Account and was invested in permitted United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act that invest only in direct U.S. government treasury obligations.

Our management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination.

Table of Contents

We will only have 24 months from the closing of the Initial Public Offering, or February 23, 2023, to complete our initial Business Combination (the “Combination Period”). If we do not complete a Business Combination within this period of time, we will (i) cease all operations except for the purposes of winding up; (ii) as promptly as reasonably possible, but not more than ten business days thereafter, redeem the Public Shares for a per share pro rata portion of the Trust Account, including interest and not previously released to us to fund our working capital requirements (subject to an annual limit of $500,000) (less taxes payable and up to $100,000 of such net interest to pay dissolution expenses) and (iii) as promptly as possible following such redemption, dissolve and liquidate the balance of our net assets to our remaining stockholders, as part of our plan of dissolution and liquidation. Our Sponsor and our executive officers and independent director nominees (the “initial stockholders”) entered into a letter agreement with us, pursuant to which they have waived their rights to participate in any redemption with respect to their Founder Shares; however, if the initial stockholders or any of our officers, directors or affiliates acquire shares of common stock in or after the Initial Public Offering, they will be entitled to a pro rata share of the Trust Account upon our redemption or liquidation in the event we do not complete a Business Combination within the required time period. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be less than the Initial Public Offering price per Unit in the Initial Public Offering.

Results of Operations

For the three months ended June 30, 2022, we had a net income of approximately $6.6 million, which included a gain from the change in fair value of warrant liabilities of $6.5 million and interest earned on marketable securities held in trust account of $0.4 million, offset mainly by a loss from operations of $0.4 million.

For the six months ended June 30, 2022, we had a net income of approximately $11.9 million, which included a gain from the change in fair value of warrant liabilities of $12.2 million and interest earned on marketable securities held in trust account of $0.5 million, offset mainly by a loss from operations of $0.8 million.

For the three months ended June 30, 2021, we had a net loss of approximately $1.09 million, which included a loss from operations of $0.23 million and loss from the change in fair value of warrant liabilities of $1 million, offset by interest earned on marketable securities held in trust account of $3,492 and gain from the change in fair value of private warrants in excess of proceeds received of $0.16 million.

For the six months ended June 30, 2021, we had a net income of approximately $0.76 million, which included interest earned on marketable securities held in trust account of $3,492 and gain from the change in fair value of warrant liabilities of $1.70 million, offset by a loss from operations of $0.32 million and offering costs allocated to warrants of $0.62 million.

Our business activities from inception to June 30, 2022 consisted primarily of our formation and completing our IPO, and since the offering, our activity has been limited to identifying and evaluating prospective acquisition targets for a Business Combination.

Liquidity, Capital Resources, and Going Concern

As of June 30, 2022, we had approximately $0.2 million in our operating bank account and working capital of approximately $0.3 million, net of franchise and income taxes payable and taxes paid out of operating funds not yet reimbursed by the Trust, as applicable, of approximately $0.2 million and $0.7 million, respectively.

For the six months ended June 30, 2022, net cash used in operating activities was approximately $0.7 million. Net income of $11.9 million was attributable to the change in fair value of warrant liabilities of $12.2 million, interest earned on marketable securities held in the Trust Account of $0.5 million and changes in operating assets and liabilities which provided $0.1 million in cash from operating activities.

For the six months ended June 30, 2021, net cash used in operating activities was approximately $0.6 million. Net income of 0.8 million was attributable to the change in fair value of warrant liability of $1.9 million, interest earned on marketable securities held in the Trust Account of $3,492, offset by offering costs allocated to warrants of $0.6 million, the fair value of private warrants in excess of proceeds received of $155,000, and changes in operating assets and liabilities, which used $0.2 million in cash from operating activities.

As of June 30, 2022, we had cash and marketable securities held in the Trust Account of approximately $287.9 million. We may withdraw interest to pay franchise and income taxes. Through June 30, 2022, cash withdrawn from the Trust Account to pay franchise and income taxes totaled $79,124 which was withdrawn during the six months ended June 30, 2022. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

As of June 30, 2022, we had cash of approximately $0.2 million held outside of our Trust Account.

Our liquidity needs up to February 23, 2021 had been satisfied through a capital contribution from the Sponsor of $25,000 (see Note 5) for the Founder shares and Class L shares, and the loan under an unsecured promissory note from the Sponsor of up to $300,000 which was paid in full on February 23, 2021 from the IPO proceeds (see Note 5).

Subsequent to the consummation of the IPO, our liquidity needs have been satisfied through the net proceeds from the consummation of the Private Placement not held in the Trust Account. In order to finance transaction costs in connection with a Business Combination, our Sponsor or certain of our officers and directors may, but are not obligated to, provide us working capital loans. Additionally, an affiliate of our Sponsor entered into a commitment letter with us whereby the affiliate of our Sponsor agreed to provide working capital loans sufficient for us to satisfy our obligations as they come due until the earlier of: (a) the completion of the initial Business Combination, or (b) liquidation. Any such working capital loan under the commitment letter will be repaid to the affiliate of our Sponsor by us upon the completion of the initial Business Combination or, in the event of liquidation prior to the completion of the initial Business Combination, forgiven by the affiliate of our Sponsor upon liquidation. As of June 30, 2022 and December 31, 2021, there were no amounts outstanding under any working capital loan and we did not have any off-balance sheet arrangements.

Table of Contents

If we do not consummate an initial business combination by February 23, 2023, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the mandatory liquidation, should an initial business combination not occur, and potential subsequent dissolution raises substantial doubt about our ability to continue as a going concern. The Company intends to consummate an initial business combination prior to February 23, 2023; however, it is uncertain whether the Company will be able to do so. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that the specific impact is not readily determinable as of the date of the balance sheet. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.

In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these unaudited condensed financial statements and the specific impact on our financial condition, results of operations, and cash flows is also not determinable as of the date of these unaudited condensed financial statements.

Contractual Obligations

We do not have any long-term debt obligations, capital lease obligations, operating lease obligations, purchase obligations or long-term liabilities.

Registration Rights

The initial stockholders and holders of the Private Placement Warrants will be entitled to registration rights pursuant to a registration rights agreement. The initial stockholders and holders of the Private Placement Warrants will be entitled to make up to three demands, excluding short form registration demands, that register such securities for sale under the Securities Act. In addition, these holders will have “piggy-back” registration rights to include their securities in other registration statements filed by us. We will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

We agreed to pay the underwriters an additional fee (the “Deferred Underwriting Fees”) of 3.5% of the gross proceeds of the IPO, or $10,062,500 in the aggregate. The Deferred Underwriting Fees will become payable to the underwriters from the amounts held in the Trust Account solely in the event that we complete a Business Combination, subject to the terms of the underwriting agreement.

Table of Contents

Critical Accounting Policies

This management’s discussion and analysis of our financial condition and results of operations is based on our unaudited condensed financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these unaudited condensed financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, income and expenses and the disclosure of contingent assets and liabilities in our unaudited condensed financial statements. On an ongoing basis, we evaluate our estimates and judgments, including those related to fair value of financial instruments and accrued expenses. We base our estimates on historical experience, known trends and events and various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

There have been no significant changes in our critical accounting policies as discussed in our Annual Report on Form 10-K for the year ended December 31, 2021 as filed with the Securities and Exchange Commission (the “SEC”) on April 13, 2022 (the “Annual Report”).

Recent Accounting Pronouncements

In August 2020, the FASB issued ASU 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. ASU 2020-06 also removes certain settlement conditions that are required for equity-linked contracts to qualify for scope exception, and it simplifies the diluted earnings per share calculation in certain areas. We early adopted ASU 2020-06 on January 1, 2021. Adoption of the ASU did not impact our financial position, results of operations or cash flows.

We do not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on our unaudited condensed financial statements.

Inflation

We do not believe that inflation had a material impact on our business or operating results during the period presented.

JOBS Act

The Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as an “emerging growth company” and under the JOBS Act are allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As a result, the unaudited condensed financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.

Additionally, we intend to rely on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, we will not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the CEO’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our Initial Public Offering or until we are no longer an “emerging growth company,” whichever is earlier.

Table of Contents

ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.

ITEM 4.

CONTROLS AND PROCEDURES

Disclosure controls are procedures that are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act, such as this Report, is recorded, processed, summarized, and reported within the time period specified in the SEC’s rules and forms. Disclosure controls are also designed with the objective of ensuring that such information is accumulated and communicated to management, including the principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based upon that evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were not effective as of June 30, 2022, due to two material weaknesses. The first material weakness in our internal controls over financial reporting relates to the proper classification of our warrants, as described in our Annual Report and in other reports the Company has filed with the SEC, including under “Item 4. Controls and Procedures” of our Quarterly Reports on Form 10-Q as filed with the SEC on May 24, 2021 and August 13, 2021, and due to the restatements of our February 23, 2021, March 31, 2021, and June 30, 2021 financial statements (the “restatements”), which were reported on the Form 10-Q as filed for the nine month period ended September 30, 2021, regarding the classification of redeemable Class A common stock. The second material weakness, identified in the current quarter, relates to the incorrect accounting for accrued liabilities, as discussed in Note 2 to the Financial Statements accompanying this Report. In light of these material weaknesses, we performed additional analysis as deemed necessary to ensure that our unaudited interim financial statements were prepared in accordance with U.S. generally accepted accounting principles. Accordingly, management believes that the unaudited condensed financial statements included in this Quarterly Report present fairly in all material respects our financial position, results of operations and cash flows for the period presented.

Changes in Internal Control over Financial Reporting

Except as set forth above, there were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that occurred during the fiscal quarter ended June 30, 2022 covered by this Quarterly Report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

To respond to the material weaknesses described above, we have devoted, and plan to continue to devote, significant effort and resources to the remediation and improvement of our internal control over financial reporting. While we have processes to identify and appropriately apply applicable accounting requirements, we plan to enhance our system of evaluating and implementing the complex accounting standards that apply to our financial statements. Our plans at this time include providing enhanced access to accounting literature, research materials and documents and increased communication among our personnel and third-party professionals with whom we consult regarding complex accounting applications, as well as enhancing our review process related to the accrued liabilities included our financial statements. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects.

PART II - OTHER INFORMATION

Item 1.

Legal Proceedings.

None.

Item 1A.

Risk Factors.

Except as set forth below, as of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in our Annual Report or disclosed in the subsequent Quarterly Report for the three months ended March 31, 2022. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. We may also disclose changes to such risk factors or disclose additional risk factors from time to time in our future filings with the SEC.

We have identified material weaknesses in our internal control over financial reporting. These material weaknesses could continue to adversely affect our ability to report our results of operations and financial condition accurately and in a timely manner.

Our management is responsible for establishing and maintaining adequate internal control over financial reporting designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP. Our management is likewise required, on a quarterly basis, to evaluate the effectiveness of our internal controls and to disclose any changes and material weaknesses identified through such evaluation in those internal controls. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.

As described in elsewhere in this Quarterly Report, during the second quarter of 2022, we identified an additional material weakness related to the incorrect accounting for certain accrued liabilities.

As described in our Annual Report, we previously identified a material weakness in our internal control over financial reporting in connection with our incorrect accounting for warrants and complex equity and equity linked instruments. The Company incorrectly accounted for the Class A common stock subject to possible redemption at the closing of our initial public offering and had also previously classified a portion of the Class A common stock in permanent equity. As a result of this material weakness, our management concluded that our internal control over financial reporting was not effective as of December 31, 2021 and also not effective as of the end of each of the interim periods during the year ended December 31, 2021. This material weakness resulted in a material misstatement of the initial carrying value of the Class A common stock subject to possible redemption and earnings per share calculations for the affected periods.

As a result of these material weaknesses, our management concluded that our internal control over financial reporting was not effective as of December 31, 2021, and remained ineffective as of June 30, 2022.

Table of Contents

To respond to these material weaknesses, we have devoted, and plan to continue to devote, significant effort and resources to the remediation and improvement of our internal control over financial reporting. While we have processes to identify and appropriately apply applicable accounting requirements, we plan to enhance these processes to better evaluate our research and understanding of the nuances of the complex accounting standards that apply to our financial statements. Our plans at this time include providing enhanced access to accounting literature, research materials and documents and increased communication among our personnel and third-party professionals with whom we consult regarding complex accounting applications, as well as enhancing our review process related to the accrued liabilities included in our financial statements. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects. For a discussion of management’s consideration of the material weaknesses identified relating to our incorrect accounting for warrants and complex equity and equity linked instruments and relating to our incorrect accounting for liability accruals, see “Part II, Item 4. Controls and Procedures”

Any failure to maintain such internal control could adversely impact our ability to report our financial position and results from operations on a timely and accurate basis. If our financial statements are not accurate, investors may not have a complete understanding of our operations and we could be subject to litigation, investigations or other proceedings by investors, the SEC or other regulatory authorities. Likewise, if our financial statements are not filed on a timely basis, we could be subject to sanctions or investigations by the stock exchange on which our common stock is listed, the SEC or other regulatory authorities. In either case, there could result a material adverse effect on our business. Ineffective internal controls could also cause investors to lose confidence in our reported financial information, which could have a negative effect on the trading price of our shares.

We can give no assurance that the measures we have taken and plan to take in the future will remediate the material weaknesses identified or that any additional material weaknesses or restatements of financial results will not arise in the future due to a failure to implement and maintain adequate internal control over financial reporting or circumvention of these controls. In addition, even if we are successful in strengthening our controls and procedures, in the future those controls, and procedures may not be adequate to prevent or identify irregularities or errors or to facilitate the fair presentation of our financial statements.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Table of Contents

Item 3.

Defaults Upon Senior Securities.

None.

Item 4.

Mine Safety Disclosures.

Not applicable.

Item 5.

Other Information.

None.

Table of Contents

Item 6.

Exhibits.

Exhibit Number		Description
31.1*		Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2*		Certification of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1**		Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2**		Certification of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS		XBRL Instance Document

101.SCH		XBRL Taxonomy Extension Schema Document

101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF		XBRL Taxonomy Extension Definition Linkbase Document

101.LAB		XBRL Taxonomy Extension Label Linkbase Document

101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document

*	Filed herewith.

These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Figure Acquisition Corp. I

	By:	/s/ Thomas J. Milani
		Name:	Thomas J. Milani
Dated: August 15, 2022		Title:	Chief Financial Officer

Figure Acquisition Corp. I 10-Q